药明合联(02268)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

02268 药明合联

交易中 12-08 14:54:57

66.950

-0.550

-0.81%

最高68.900	最低66.100	成交量158.40万
今开68.700	昨收67.500	日振幅4.15%
总市值838.88亿	流通市值838.88亿	总股本12.53亿
成交额1.06亿	换手率0.13%	流通股本12.53亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"02268","market":"HK","secType":"STK","nameCN":"药明合联","latestPrice":66.95,"timestamp":1765176864153,"preClose":67.5,"halted":0,"volume":1584017,"delay":0,"floatShares":1253000000,"shares":1253000000,"eps":0.9826267957986462,"marketStatus":"交易中","change":-0.55,"latestTime":"12-08 14:54:57","open":68.7,"high":68.9,"low":66.1,"amount":105794884,"amplitude":0.041481,"askPrice":66.95,"askSize":3500,"bidPrice":66.9,"bidSize":7000,"shortable":3,"etf":0,"ttmEps":1.1236349542674862,"tradingStatus":2,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1765181400000},"marketStatusCode":2,"adr":0,"listingDate":1700150400000,"exchange":"SEHK","adjPreClose":67.5,"openAndCloseTimeList":[[1765157400000,1765166400000],[1765170000000,1765180800000]],"volumeRatio":0.561811,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/02268","defaultTab":"news","newsList":[{"id":"2589402852","title":"【券商聚焦】交银国际：医药行业短期催化剂充足 长期继续看好创新主线","url":"https://stock-news.laohu8.com/highlight/detail?id=2589402852","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2589402852?lang=zh_cn&edition=full","pubTime":"2025-12-05 10:38","pubTimestamp":1764902337,"startTime":"0","endTime":"0","summary":"金吾财讯 | 交银国际表示，2025年10月以来，内资通过港股通持有医药股的比例小幅下降，外资持仓从年中起亦呈回落态势，但内外资加大创新药布局的大方向不变。而外资则更积极，聚焦创新主线中的龙头及产业链上游，包括恒瑞医药、君实生物和荣昌生物等创新药，及康龙化成、药明康德和泰格医药等CXO标的。12月，行业仍有充足催化剂，包括各项学术大会、医保谈判结果公布、美联储潜在降息等，板块投资情绪有望稳中有升。","market":"sh","thumbnail":"https://static.szfiu.com/news/20250109/MWU1MjY1NDI2Mjg5NDIzOQ==.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250109/MWU1MjY1NDI2Mjg5NDIzOQ==.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1970976","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0561508036.HKD","LU1303224171.USD","02268","BK1147","IE00BPRC5H50.USD","01789","BK1500","SG9999004311.SGD","01530","03933","BK1585","BK1141","LU0640798160.USD","BK1583","BK1197","BK1588","06160","LU1794554557.SGD","09926","LU1969619763.USD","LU0540923850.HKD","LU2488822045.USD","IE00B5MMRT66.SGD","BK1161","LU0634319403.HKD","IE00B543WZ88.USD","01099","SG9999014674.SGD","BK1617","02367","LU0348825331.USD","LU1770034418.SGD","02228","LU0348827113.USD","LU1251922891.USD","LU2328871848.SGD","LU2399975544.HKD","LU2476274308.USD","LU0417516571.SGD","03329","02196","09688","LU2778985437.USD","LU2476274720.SGD","BK1593","LU0348766576.USD","LU0417516902.SGD","HK0000165453.HKD","LU0588546209.SGD","LU0417516738.SGD"],"gpt_icon":1},{"id":"2589852755","title":"交银国际：中国医药1-8批国采接续规则或温和 短期催化剂充足","url":"https://stock-news.laohu8.com/highlight/detail?id=2589852755","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2589852755?lang=zh_cn&edition=full","pubTime":"2025-12-05 10:18","pubTimestamp":1764901122,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，交银国际发布研报称，本周恒生医疗保健指数涨0.5%，跑输大市。其中，生物药、处方药及器械板块表现较优于其他板块。本周内资偏向防御，倾向获利了结，主要加仓内生增长稳定的传统及低估创新药厂。而外资则较积极，聚焦创新主线中的龙头及产业链上游，包括创新药及CXO标的。1-8批集采接续采购规则转变为询价模式，交银国际认为此规则下整体降价幅度或有限，对港股处方药厂的影响或小于预期。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1378013.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1587","LU2488822045.USD","SG9999014674.SGD","BK1593","BK1147","HK0000165453.HKD","01530","BK1583","06996","BK0188","BK1161","BK0028","BK0185","BK0250","02268","03329","BK1588","BK1141","02096","00013","BK1574","BK0010","BK1191","BK0175","BK0082","600056"],"gpt_icon":0},{"id":"1136002031","title":"药明合联（2268）更新2025年11月股份变动月报表，总股本小幅增加","url":"https://stock-news.laohu8.com/highlight/detail?id=1136002031","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1136002031?lang=zh_cn&edition=full","pubTime":"2025-12-04 17:19","pubTimestamp":1764839978,"startTime":"0","endTime":"0","summary":"药明合联生物技术有限公司于2025年12月4日发布2025年11月股份变动月报表。报告显示，截至2025年11月30日，公司注册股本维持在10,000,000,000股普通股，面值0.00005美元，法定/注册股本总额保持500,000美元不变。无股份购回、注销或库存股变动记录。此外，公司董事会于过去数次会议批准了一项2024年股份计划，截至报告期末，根据该计划尚可发行普通股合计10,285,226股，本月内并未新增发行。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02268"],"gpt_icon":0},{"id":"2588002629","title":"每日卖空追踪 | 药明合联 12月04日卖空量成交5.75万股，卖空比例为1.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2588002629","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588002629?lang=zh_cn&edition=full","pubTime":"2025-12-04 16:30","pubTimestamp":1764837030,"startTime":"0","endTime":"0","summary":"药明合联北京时间12月04日，涨7.51%，卖空量成交5.75万股，较上一交易日减少89.53%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251204163444952a7beb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251204163444952a7beb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SG9999014674.SGD","LU2488822045.USD","BK1141","02268"],"gpt_icon":0},{"id":"2588200260","title":"药明合联12月04日主力净流入1562.4万元 散户资金抛售","url":"https://stock-news.laohu8.com/highlight/detail?id=2588200260","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588200260?lang=zh_cn&edition=full","pubTime":"2025-12-04 16:15","pubTimestamp":1764836138,"startTime":"0","endTime":"0","summary":"12月04日, 药明合联股价涨7.51%，报收68.00元，成交金额3.7亿元，换手率0.45%，振幅8.54%，量比1.47。药明合联今日主力资金净流入1562.4万元，上一交易日主力净流出585.3万元。该股近5个交易日上涨4.81%，主力资金累计净流入998.4万元，其中1个交易日为股价下跌时净流入；近20日主力资金累计净流入5475.7万元，其中净流入天数为13日。该股主力净额占比0.02%，港股市场排名263/2683。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251204161845952a7294&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251204161845952a7294&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SG9999014674.SGD","LU2488822045.USD","BK1141","02268"],"gpt_icon":0},{"id":"1114177897","title":"港股药明系短线拉升！药明生物涨近7%，药明合联涨超4%","url":"https://stock-news.laohu8.com/highlight/detail?id=1114177897","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1114177897?lang=zh_cn&edition=full","pubTime":"2025-12-04 14:36","pubTimestamp":1764830175,"startTime":"0","endTime":"0","summary":"药明系短线拉升，$药明生物(02269)$涨近7%，$药明合联(02268)$涨超4%，$药明康德(603259)$涨超3%。","market":"hk","thumbnail":"https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"8ece981a1ccfcd1a76894a7d36bcad57","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02359","02269","02268"],"gpt_icon":0},{"id":"2588000298","title":"药明合联荣获“最佳港股通公司”大奖，彰显稳健价值与投资标杆地位","url":"https://stock-news.laohu8.com/highlight/detail?id=2588000298","media":"动脉网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588000298?lang=zh_cn&edition=full","pubTime":"2025-12-03 20:04","pubTimestamp":1764763440,"startTime":"0","endTime":"0","summary":"2025年12月3日，在“第十届智通财经上市公司颁奖盛典”上，药明合联(02268)凭借健全公司治理、突出行业地位、稳健主营业务及持续价值回报能力，荣获“最佳港股通公司”大奖，体现资本市场对其投资价值与管理能力的高度认可。该评选自2016年启动，是中国资本市场权威性高、公信力强的年度盛事，本届评选历时一个多月，经多重环节，从多方面综合评估，最终遴选出各领域标杆企业。评选吸引超千家港美股企业参与，涵盖新兴高增长领域与传统主流行业。颁奖典礼现场，逾170位机构代表与知名人士及上千名专业投资者共聚，围绕资产配置策略与港股投资机遇交流。期待获奖企业持续提升竞争力，为经济与社会进步贡献力量。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251203201819978dd72d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251203201819978dd72d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU2488822045.USD","SG9999014674.SGD","BK1141","02268"],"gpt_icon":0},{"id":"2588461054","title":"药明合联12月02日遭主力抛售780.1万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2588461054","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588461054?lang=zh_cn&edition=full","pubTime":"2025-12-02 16:15","pubTimestamp":1764663358,"startTime":"0","endTime":"0","summary":"12月02日, 药明合联股价跌0.91%，报收65.45元，成交金额1.2亿元，换手率0.15%，振幅2.27%，量比0.48。药明合联今日主力资金净流出780.1万元，上一交易日主力净流出71.7万元。该股近5个交易日下跌2.09%，主力资金累计净流入1766.7万元，其中1个交易日为股价上涨时净流出；近20日主力资金累计净流入4841.6万元，其中净流入天数为14日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251202162221a4c797cb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251202162221a4c797cb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02268","LU2488822045.USD","BK1141","SG9999014674.SGD"],"gpt_icon":0},{"id":"2588828820","title":"行业回暖！盘点2025年CXO订单最高的10家公司：药明系领跑，凯莱英、泰格医药等巨头订单激增","url":"https://stock-news.laohu8.com/highlight/detail?id=2588828820","media":"摩熵医药","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588828820?lang=zh_cn&edition=full","pubTime":"2025-12-02 11:01","pubTimestamp":1764644506,"startTime":"0","endTime":"0","summary":"2025年，全球CXO行业在逐步回暖，市场需求结构性分化愈发明显。2025前三季度实现营业收入328.57亿元，同比增长18.61%；归属于上市公司股东净利润120.76亿元，同比大增84.84%。截至2025 年9月末，TIDES 在手订单同比增长 17.1%。药明生物截至2025年6月30日收益同比增长16.1%，达人民币99.53亿元。凯莱英、康龙化成、泰格医药及方达控股凯莱英截止2025年Q3总营收达46.3亿，同比增长11.82%。方达控股截止2025年6月30日营收1.27亿，同比下滑1.48%，净利润292.7万，同比增长2600%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251202110317a71e24b3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251202110317a71e24b3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1583","LU2488822045.USD","03759","03347","SG9999014674.SGD","02268","BK1191","06821","BK1576","BK1141"],"gpt_icon":0},{"id":"2588885590","title":"每日卖空追踪 | 药明合联 12月01日卖空量成交8.9万股，卖空比例为4.28%","url":"https://stock-news.laohu8.com/highlight/detail?id=2588885590","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588885590?lang=zh_cn&edition=full","pubTime":"2025-12-01 16:30","pubTimestamp":1764577828,"startTime":"0","endTime":"0","summary":"药明合联北京时间12月01日，涨0.92%，卖空量成交8.9万股，较上一交易日减少32.83%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251201163359a4c55135&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251201163359a4c55135&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU2488822045.USD","02268","BK1141","SG9999014674.SGD"],"gpt_icon":0},{"id":"2588716251","title":"药明合联(02268)因期权获行使而发行合共111.33万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2588716251","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588716251?lang=zh_cn&edition=full","pubTime":"2025-12-01 07:40","pubTimestamp":1764546049,"startTime":"0","endTime":"0","summary":"智通财经APP讯，药明合联(02268)发布公告，于2025年11月4日-11月28日因期权获行使而发行合共111.33万股。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1375714.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02268","SG9999014674.SGD","LU2488822045.USD","BK1141"],"gpt_icon":0},{"id":"2587757009","title":"药明生物与子公司药明合联宣布共同捐赠1000万港元，支援香港大埔火灾救助","url":"https://stock-news.laohu8.com/highlight/detail?id=2587757009","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2587757009?lang=zh_cn&edition=full","pubTime":"2025-11-29 16:57","pubTimestamp":1764406663,"startTime":"0","endTime":"0","summary":"每经AI快讯，11月29日，据药明生物微信公众号，为支援救灾工作推进，药明生物与子公司药明合联宣布，共同捐赠1000万港元专项善款，用于受灾民众的医疗救治、紧急安置、物资补给和灾后恢复等急需环节。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202511293578306621.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202511293578306621.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["LU1720050803.USD","LU0516423091.SGD","LU0516422952.EUR","LU0039217434.USD","LU0417516738.SGD","BK1576","LU0051755006.USD","LU0856984785.SGD","SG9999002562.SGD","LU0327786744.USD","LU0588546209.SGD","LU0823426308.USD","LU0320764599.SGD","LU0516423174.USD","LU0456846285.SGD","IE00B0JY6N72.USD","LU0456827905.SGD","LU0307460666.USD","02268","LU0819121731.USD","LU1880383366.USD","LU2039709279.SGD","LU0417516902.SGD","LU0359202008.SGD","LU3063872942.SGD","BK1141","LU0572944931.SGD","LU0181495838.USD","LU1242518857.USD","LU1242518931.SGD","LU0348825331.USD","LU0348735423.USD","LU0516422440.USD","SG9999014674.SGD","BK1610","02269","LU0043850808.USD","LU0979878070.USD","LU0052750758.USD","BK1589","LU2488822045.USD","LU0359201612.USD","LU0823426480.USD","SG9999002463.SGD","LU0708995583.HKD","LU0516422366.SGD","LU0140636845.USD","BK1521","LU0326950275.SGD","LU1688375341.USD"],"gpt_icon":0},{"id":"2586200500","title":"每日卖空追踪 | 药明合联 11月28日卖空量成交7.2万股，卖空比例为2.73%","url":"https://stock-news.laohu8.com/highlight/detail?id=2586200500","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586200500?lang=zh_cn&edition=full","pubTime":"2025-11-28 16:30","pubTimestamp":1764318626,"startTime":"0","endTime":"0","summary":"药明合联北京时间11月28日，跌0.15%，卖空量成交7.2万股，较上一交易日减少88.47%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251128164402a4bffb92&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251128164402a4bffb92&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1141","SG9999014674.SGD","02268","LU2488822045.USD"],"gpt_icon":0},{"id":"2586422639","title":"药明合联11月25日主力净流出514.9万元 散户资金买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2586422639","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586422639?lang=zh_cn&edition=full","pubTime":"2025-11-25 16:15","pubTimestamp":1764058542,"startTime":"0","endTime":"0","summary":"11月25日, 药明合联股价跌1.47%，报收66.90元，成交金额2.7亿元，换手率0.32%，振幅3.98%，量比0.71。药明合联今日主力资金净流出514.9万元，上一交易日主力净流入681.8万元。该股近5个交易日下跌0.07%，主力资金累计净流出604.2万元；近20日主力资金累计净流入7261.3万元，其中净流入天数为15日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251125161934a4b8f421&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251125161934a4b8f421&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU2488822045.USD","SG9999014674.SGD","02268","BK1141"],"gpt_icon":0},{"id":"2585050467","title":"上海重磅发布！医药产业又迎政策支持 机构看好创新药产业链","url":"https://stock-news.laohu8.com/highlight/detail?id=2585050467","media":"券商中国","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2585050467?lang=zh_cn&edition=full","pubTime":"2025-11-24 20:55","pubTimestamp":1763988955,"startTime":"0","endTime":"0","summary":"医药产业，又迎来政策支持！值得关注的是，近日多家券商研究机构发布研报，表示看好创新医疗器械以及创新药产业链。上海重磅发布日前，上海市人民政府办公厅印发《上海市全面深化药品医疗器械监管改革促进医药产业高质量发展的若干措施》。在国家医保药品和“新优药械”产品目录发布1个月内，根据临床需求和医院特色，及时配备使用。看好创新药产业链、创新医疗器械。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251124205450a70e6201&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251124205450a70e6201&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["01177","02268","BK1191","BK1574","BK1588","01801","BK1161","06978","01548","02228","00867","01877","00013","BK1587","02359","03692"],"gpt_icon":0},{"id":"2585045783","title":"每日卖空追踪 | 药明合联 11月24日卖空量成交12.2万股，卖空比例为0.96%","url":"https://stock-news.laohu8.com/highlight/detail?id=2585045783","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2585045783?lang=zh_cn&edition=full","pubTime":"2025-11-24 16:30","pubTimestamp":1763973028,"startTime":"0","endTime":"0","summary":"药明合联北京时间11月24日，涨2.18%，卖空量成交12.2万股，较上一交易日减少69.31%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251124163412977c1ef7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251124163412977c1ef7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU2488822045.USD","BK1141","SG9999014674.SGD","02268"],"gpt_icon":0},{"id":"2585457859","title":"药明合联11月24日主力净流入681.8万元 散户资金抛售","url":"https://stock-news.laohu8.com/highlight/detail?id=2585457859","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2585457859?lang=zh_cn&edition=full","pubTime":"2025-11-24 16:15","pubTimestamp":1763972108,"startTime":"0","endTime":"0","summary":"11月24日, 药明合联股价涨2.18%，报收67.90元，成交金额8.6亿元，换手率1.01%，振幅3.76%，量比3.21。药明合联今日主力资金净流入681.8万元，上一交易日主力净流出1688.2万元。该股近5个交易日下跌1.38%，主力资金累计净流入178.1万元；近20日主力资金累计净流入5502.6万元，其中净流入天数为15日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251124161526977c132d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251124161526977c132d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SG9999014674.SGD","LU2488822045.USD","BK1141","02268"],"gpt_icon":0},{"id":"2585455474","title":"《大行》大摩：药明系估值吸引 首选药明康德A股","url":"https://stock-news.laohu8.com/highlight/detail?id=2585455474","media":"AASTOCKS","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2585455474?lang=zh_cn&edition=full","pubTime":"2025-11-24 11:39","pubTimestamp":1763955547,"startTime":"0","endTime":"0","summary":"大摩最看好药明康德，因此该公司不仅上调业绩指引，更进行大规模产能扩张，且在下一代GLP-1领域参与度高。该行提到，药明康德A股为投资者带来理想的买入机会，上调公司2025至27年盈测3至4%，并列为首选股；将药明生物2025至27年盈测调升6至13%；升药明合联盈测7至8%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251124120206a70d61b5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":"cbcf7c1647e08bae3304b28bf41bd5cc","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251124120206a70d61b5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02359","BK1576","BK1141","LU0320764599.SGD","LU2045819591.USD","LU0052750758.USD","02268","LU1046422090.SGD","BK1583","LU0708995583.HKD","LU2242644610.SGD","LU2125910500.SGD"],"gpt_icon":0},{"id":"2585274430","title":"创新药概念股涨幅居前 三生制药涨5.11% 机构指医药行业有望在2026年重启升势","url":"https://stock-news.laohu8.com/highlight/detail?id=2585274430","media":"金吾资讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2585274430?lang=zh_cn&edition=full","pubTime":"2025-11-24 09:56","pubTimestamp":1763949363,"startTime":"0","endTime":"0","summary":"金吾财讯 | 创新药概念股涨幅居前，截至发稿，三生制药 涨5.11%，恒瑞医药涨4.40%，科伦博泰生物-B涨4.03%，信达生物涨3.50%，康方生物涨2.71%，药明合联涨2.56%，药明康德涨2.36%。该机构看好2026年医药行业投资机会，近期震荡调整后估值已回落至相对低位，有望在2026年重启升势，投资思路上寻找医药硬科技和细分赛道α，推荐关注创新药、创新器械、医疗AI方向，关注医药消费复苏及独立第三方ICL。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251124095644a4b5e788&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251124095644a4b5e788&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["06978","02268","01530","HK0000165453.HKD","BK1583","01801","BK1141","LU2488822045.USD","BK1593","BK1161","SG9999014674.SGD","BK1574","02359"],"gpt_icon":0},{"id":"2585543022","title":"千亿轮回：康方生物、科伦博泰、药明合联","url":"https://stock-news.laohu8.com/highlight/detail?id=2585543022","media":"会会药咖","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2585543022?lang=zh_cn&edition=full","pubTime":"2025-11-24 08:00","pubTimestamp":1763942439,"startTime":"0","endTime":"0","summary":"今日随着最新一轮回调，康方生物盘中跌去4.77%，市值重回千亿港币以下，这是继科伦博泰和药明合联后，近期再一轮回千亿的企业。2025年8月5日，科伦博泰首次冲上千亿市值宝座，一度在10月3日达到1354亿港币市值，上市两年多以来，股价上涨超过8倍。康方生物、科伦博泰、药明合联市值跌破千亿，不仅是市场情绪的冷却，更是行业从“估值驱动”向“业绩驱动”转型的标志。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251124081103a70cf2c2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251124081103a70cf2c2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1574","IE00BPRC5H50.USD","LU0348827113.USD","IE00B5MMRT66.SGD","LU1720050803.USD","LU1961090484.USD","LU0348767384.USD","LU0348825331.USD","09926","LU0348735423.USD","02268","LU0561508036.HKD","LU2778985437.USD","LU2488822045.USD","BK1141","LU0417516902.SGD","LU0417516738.SGD","LU1794554557.SGD","LU0348766576.USD","LU2476274720.SGD","LU2476274308.USD","BK1161","LU0540923850.HKD","IE00B543WZ88.USD","LU0634319403.HKD","LU0417516571.SGD","LU0348783233.USD","LU2399975544.HKD","SG9999014674.SGD","LU0348784397.USD"],"gpt_icon":0}],"profile":{"websiteUrl":"http://wuxixdc.com","stockEarnings":[{"period":"1week","weight":0.0313},{"period":"1month","weight":-0.0473},{"period":"3month","weight":0.0321},{"period":"6month","weight":0.6187},{"period":"1year","weight":1.4501},{"period":"ytd","weight":1.2023}],"compareEarnings":[{"period":"1week","weight":0.0087},{"period":"1month","weight":0.0058},{"period":"3month","weight":0.0262},{"period":"6month","weight":0.0964},{"period":"1year","weight":0.3336},{"period":"ytd","weight":0.3004}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"药明合联生物技术有限公司是一家主要从事提供提供抗体偶联药物（ADC）及其他生物偶联药物的全面合同研究、开发及制造组织（CRDMO）服务的投资控股公司。该公司的服务包括生物偶联药物、单克隆抗体中间体及生物偶联药物相关连接子及有效载荷的发现、工艺开发及优良生产质量管理规范（GMP）生产。该公司透过按有偿服务（FFS）基准的合约和按全时当量（FTE）基准的合约向客户提供CRDMO服务。该公司主要在国内市场、北美、欧洲和世界其他地区市场开展业务。","yearOnYearQuotes":[{"month":1,"riseRate":0.222222,"avgChangeRate":0.010265},{"month":2,"riseRate":0.666667,"avgChangeRate":0.058284},{"month":3,"riseRate":0.333333,"avgChangeRate":-0.010372},{"month":4,"riseRate":0.555556,"avgChangeRate":0.03555},{"month":5,"riseRate":0.333333,"avgChangeRate":0.006014},{"month":6,"riseRate":0.4,"avgChangeRate":-0.032735},{"month":7,"riseRate":0.4,"avgChangeRate":0.011785},{"month":8,"riseRate":0.4,"avgChangeRate":-0.114063},{"month":9,"riseRate":0.333333,"avgChangeRate":0.019767},{"month":10,"riseRate":0.777778,"avgChangeRate":0.151657},{"month":11,"riseRate":0.333333,"avgChangeRate":0.008796},{"month":12,"riseRate":0.111111,"avgChangeRate":-0.068876}],"exchange":"SEHK","name":"药明合联","nameEN":"WUXI XDC"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.10","shortVersion":"4.35.10","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"药明合联(02268)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供药明合联(02268)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"药明合联,02268,药明合联股票,药明合联股票老虎,药明合联股票老虎国际,药明合联行情,药明合联股票行情,药明合联股价,药明合联股市,药明合联股票价格,药明合联股票交易,药明合联股票购买,药明合联股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"药明合联(02268)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供药明合联(02268)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}